首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1378754

腎去神經系統市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Renal Denervation Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年，全球腎去神經系統市場規模達到3.18億美元。展望未來， IMARC Group預計到2028年市場規模將達到23.62億美元，2022-2028年複合年成長率（CAGR）為39.7%。

腎去神經術 (RDN) 是一種介入性手術，涉及透過導管消融腎動脈壁內的交感神經。它最大限度地破壞神經，降低腎素分泌，刺激尿鈉，並改善腎臟血流動力學或血流量。因此，RDN 系統廣泛用於治療頑固性高血壓病例，其中最佳治療無法緩解患者的症狀。

由於吸煙和飲酒的人數不斷增加、不健康飲食模式的增加、久坐和忙碌的生活方式以及老年人口的不斷增加，高血壓等生活方式疾病的患病率顯著上升，這是關鍵因素之一加強市場成長。除此之外，與RDN系統相關的優勢，如快速恢復、安全、時間效率和成本效益，是另一個主要的成長誘導因素。此外，微創（MI）手術不斷成長的需求也促進了市場的成長。微輸液技術的引入、醫療保健基礎設施的改善、研發（R&D）活動的增加以及系統監管批准申請數量的增加，也對市場成長產生了積極影響。儘管如此，由於冠狀病毒病（COVID-19）病例激增，醫院就診次數減少以及選擇性醫療程序的重新安排影響了市場成長。

本報告回答的關鍵問題：

迄今為止，全球腎臟去神經系統市場表現如何，未來幾年將如何表現？
主要區域市場有哪些？
COVID-19 對全球去腎神經系統市場有何影響？
依產品類型分類的市場是怎麼樣的？
基於產品的市場區隔是什麼？
基於技術的市場區隔是什麼？
基於應用程式的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球去腎神經系統市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太地區
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 12 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 15 章：價格分析

第16章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Boston Scientific Group
- Kona Medical Inc.
- Medtronic Plc
- Mercator MedSystems
- ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
- Renal Dynamics
- St. Jude Medical Inc. (Abbott)
- Terumo Corporation

簡介目錄圖表

Product Code: SR112023A2558

Abstract

The global renal denervation systems market size reached US$ 318 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,362 Million by 2028, exhibiting a growth rate (CAGR) of 39.7% during 2022-2028.

Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.

A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. The introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are also creating a positive influence on the market growth. Although, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) have impacted the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, product, technology, application and end user.

Breakup by Product Type:

Catheters

Single Electrode Catheter

Multi Electrode Catheter

RF Generator

Nerve Modifying Agents

Breakup by Product:

Symplicity

Vessix (V2)

EnligHTN

Paradise

Iberis

Others

Breakup by Technology:

Ultrasound Ablation

Radiofrequency Ablation

Microinfusion

Breakup by Application:

Hypertension

Cardiac Disorders

Diabetes

Renal Failure

Others

Breakup by End User:

Diagnostic Centers and Hospitals

Ambulatory Care Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.

Key Questions Answered in This Report:

How has the global renal denervation systems market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global renal denervation systems market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global renal denervation systems market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Renal Denervation Systems Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type

6.1 Catheters
- 6.1.1 Market Trends
- 6.1.2 Major Types
  - 6.1.2.1 Single Electrode Catheter
  - 6.1.2.2 Multi Electrode Catheter
- 6.1.3 Market Forecast
6.2 RF Generator
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Nerve Modifying Agents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast

7 Market Breakup by Product

7.1 Symplicity
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Vessix (V2)
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 EnligHTN
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Paradise
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Iberis
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Technology

8.1 Ultrasound Ablation
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Radiofrequency Ablation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Microinfusion
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Application

9.1 Hypertension
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Cardiac Disorders
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Diabetes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Renal Failure
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
9.5 Others
- 9.5.1 Market Trends
- 9.5.2 Market Forecast

10 Market Breakup by End User

10.1 Diagnostic Centers and Hospitals
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
10.2 Ambulatory Care Centers
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast

11 Market Breakup by Region

11.1 North America
- 11.1.1 United States
  - 11.1.1.1 Market Trends
  - 11.1.1.2 Market Forecast
- 11.1.2 Canada
  - 11.1.2.1 Market Trends
  - 11.1.2.2 Market Forecast
11.2 Asia Pacific
- 11.2.1 China
  - 11.2.1.1 Market Trends
  - 11.2.1.2 Market Forecast
- 11.2.2 Japan
  - 11.2.2.1 Market Trends
  - 11.2.2.2 Market Forecast
- 11.2.3 India
  - 11.2.3.1 Market Trends
  - 11.2.3.2 Market Forecast
- 11.2.4 South Korea
  - 11.2.4.1 Market Trends
  - 11.2.4.2 Market Forecast
- 11.2.5 Australia
  - 11.2.5.1 Market Trends
  - 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
  - 11.2.6.1 Market Trends
  - 11.2.6.2 Market Forecast
- 11.2.7 Others
  - 11.2.7.1 Market Trends
  - 11.2.7.2 Market Forecast
11.3 Europe
- 11.3.1 Germany
  - 11.3.1.1 Market Trends
  - 11.3.1.2 Market Forecast
- 11.3.2 France
  - 11.3.2.1 Market Trends
  - 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
  - 11.3.3.1 Market Trends
  - 11.3.3.2 Market Forecast
- 11.3.4 Italy
  - 11.3.4.1 Market Trends
  - 11.3.4.2 Market Forecast
- 11.3.5 Spain
  - 11.3.5.1 Market Trends
  - 11.3.5.2 Market Forecast
- 11.3.6 Russia
  - 11.3.6.1 Market Trends
  - 11.3.6.2 Market Forecast
- 11.3.7 Others
  - 11.3.7.1 Market Trends
  - 11.3.7.2 Market Forecast
11.4 Latin America
- 11.4.1 Brazil
  - 11.4.1.1 Market Trends
  - 11.4.1.2 Market Forecast
- 11.4.2 Mexico
  - 11.4.2.1 Market Trends
  - 11.4.2.2 Market Forecast
- 11.4.3 Others
  - 11.4.3.1 Market Trends
  - 11.4.3.2 Market Forecast
11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast

12 SWOT Analysis

12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
- 16.3.1 Boston Scientific Group
  - 16.3.1.1 Company Overview
  - 16.3.1.2 Product Portfolio
  - 16.3.1.3 Financials
  - 16.3.1.4 SWOT Analysis
- 16.3.2 Kona Medical Inc.
  - 16.3.2.1 Company Overview
  - 16.3.2.2 Product Portfolio
- 16.3.3 Medtronic Plc
  - 16.3.3.1 Company Overview
  - 16.3.3.2 Product Portfolio
  - 16.3.3.3 Financials
  - 16.3.3.4 SWOT Analysis
- 16.3.4 Mercator MedSystems
  - 16.3.4.1 Company Overview
  - 16.3.4.2 Product Portfolio
- 16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
  - 16.3.5.1 Company Overview
  - 16.3.5.2 Product Portfolio
- 16.3.6 Renal Dynamics
  - 16.3.6.1 Company Overview
  - 16.3.6.2 Product Portfolio
- 16.3.7 St. Jude Medical Inc. (Abbott)
  - 16.3.7.1 Company Overview
  - 16.3.7.2 Product Portfolio
- 16.3.8 Terumo Corporation
  - 16.3.8.1 Company Overview
  - 16.3.8.2 Product Portfolio
  - 16.3.8.3 Financials
  - 16.3.8.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Renal Denervation Systems Market: Major Drivers and Challenges
Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2022
Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2022
Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2022
Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2022
Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2022
Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
Figure 100: Global: Renal Denervation Systems Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Renal Denervation Systems Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Renal Denervation Systems Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Renal Denervation Systems Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Renal Denervation Systems Market Forecast: Breakup by Technology (in Million US$), 2023-2028
Table 5: Global: Renal Denervation Systems Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 6: Global: Renal Denervation Systems Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 7: Global: Renal Denervation Systems Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 8: Global: Renal Denervation Systems Market Structure
Table 9: Global: Renal Denervation Systems Market: Key Players

02-2729-4219

+886-2-2729-4219